Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

45 recalls, newest first

Class II · Moderate risk

Doctor Manzanilla Cough & Cold

CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.

Terminated Microbial contamination Mid Valley Pharmaceutical D-1136-2017
Class II · Moderate risk

Ninjacof-A

Microbial contamination of Non-sterile Products; potential B. cepacia contamination

Terminated Microbial contamination Centurion Labs, LLC NDC 23359-033-16 D-1141-2017
Class II · Moderate risk

Rugby Aller-chlor

Microbial Contamination of Non Sterile Product; presence of yeast and potential B. cepacia contamination

Terminated Microbial contamination Pharmatech LLC D-0227-2018
Class II · Moderate risk

Rugby Diocto Syrup

Microbial Contamination of Non Sterile Product; presence of yeast and potential B. cepacia contamination

Terminated Microbial contamination Pharmatech LLC D-0225-2018
Class II · Moderate risk

Rugby Diocto Liquid

Microbial Contamination of Non Sterile Product; presence of yeast and potential B. cepacia contamination

Terminated Microbial contamination Pharmatech LLC D-0224-2018
Class II · Moderate risk

Rugby Aller-chlor

Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination

Terminated Microbial contamination The Harvard Drug Group D-1122-2017
Class II · Moderate risk

Rugby Diocto Syrup

Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination

Terminated Microbial contamination The Harvard Drug Group D-1120-2017
Class II · Moderate risk

Rugby Diocto Liquid

Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination

Terminated Microbial contamination The Harvard Drug Group D-1119-2017
Class II · Moderate risk

Magnesium Citrate Oral Solution

Microbial contamination of non-sterile products: product was found to contain mold, identified as Rhinocladiella similis.

Terminated Microbial contamination Vi-Jon, Inc. NDC 50804-686-38 D-1054-2017
Class II · Moderate risk

Lactulose Solution

Microbial contamination of non-sterile product: product failed Total Yeast/Mold Count specification.

Terminated Microbial contamination VistaPharm, Inc. NDC 66689-038-01 D-1053-2017
Class II · Moderate risk

Lactulose Solution

Microbial contamination of non-sterile product: product failed Total Yeast/Mold Count specification.

Terminated Microbial contamination VistaPharm, Inc. NDC 66689-038-50 D-1052-2017

Recalls by year